A newborn screening program involves analyzing a blood sample taken from the baby's heel to detect a range of serious congenital disorders. This typically includes screening for congenital hypothyroidism, cystic fibrosis (CF), metabolic disorders of amino acids and organic acids, and fatty acid oxidation, as well as other conditions as determined by the national program.